{"_buckets": {"deposit": "962e6224-27ca-4d25-bfcc-371049a4063f"}, "_deposit": {"id": "3743", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "3743"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00003743"}, "item_6_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2012-06-21", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "13", "bibliographicPageEnd": "1831", "bibliographicPageStart": "1824", "bibliographicVolumeNumber": "586", "bibliographic_titles": [{"bibliographic_title": "FEBS LETTERS"}]}]}, "item_6_description_20": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "Uterine leiomyosarcoma (LMS) is a highly metastatic smooth muscle neoplasm for which calponin h1 is suspected to have a biological role as a tumor-suppressor. We earlier reported that LMP2-null mice spontaneously develop uterine LMS through malignant transformation of the myometrium, thus implicating this protein as an anti-tumorigenic candidate as well. In the present study, we show that LMP2 may negatively regulate LMS independently of its role in the proteasome. Moreover, several lines of evidence indicate that although calponin h1 does not directly influence tumorigenesis, it clearly affects LMP2-induced cellular morphological changes. Modulation of LMP2 may lead to new therapeutic approaches in human uterine LMS.", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7\uff08\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u7a2e\u985e\uff09", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "\u5f15\u7528", "attribute_value_mlt": [{"subitem_description": "FEBS LETTERS. 586(13):1824-1831 (2012)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "\u4fe1\u5dde\u5927\u5b66\u7814\u7a76\u8005\u7dcf\u89a7\u3078\u306e\u30ea\u30f3\u30af", "attribute_value_mlt": [{"subitem_link_text": "Shiozawa, Tanri", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.jmyCupkh.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=2\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000305405000013"}]}, "item_6_publisher_4": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "ELSEVIER SCIENCE BV"}]}, "item_6_relation_47": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "22659265"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search\u0026DB=pubmed\u0026term=22659265", "subitem_relation_type_select": "PMID"}}]}, "item_6_relation_48": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1016/j.febslet.2012.05.029"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://dx.doi.org/10.1016/j.febslet.2012.05.029", "subitem_relation_type_select": "DOI"}}]}, "item_6_rights_62": {"attribute_name": "\u6a29\u5229", "attribute_value_mlt": [{"subitem_rights": "Copyright\u00a9 2012 Federation of European Biochemical Societies. Published by Elsevier B. V."}]}, "item_6_select_64": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "author"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0014-5793", "subitem_source_identifier_type": "ISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0014-5793", "subitem_source_identifier_type": "ISSN"}]}, "item_6_source_id_40": {"attribute_name": "\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00642943", "subitem_source_identifier_type": "NCID"}]}, "item_6_text_69": {"attribute_name": "wosonly authkey", "attribute_value_mlt": [{"subitem_text_value": "LMP2; Calponin h1; Uterine leiomyosarcoma; Cell morphology"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "SMOOTH; PROTEASOME; EXPRESSION; GENE; UTERUS; TUMORS; JAK1; PROGRESSION; SUBUNITS; ESTROGEN"}]}, "item_6_textarea_68": {"attribute_name": "wosonly abstract", "attribute_value_mlt": [{"subitem_textarea_value": "Uterine leiomyosarcoma (LMS) is a highly metastatic smooth muscle neoplasm for which calponin h1 is suspected to have a biological role as a tumor-suppressor. We earlier reported that LMP2-null mice spontaneously develop uterine LMS through malignant transformation of the myometrium, thus implicating this protein as an anti-tumorigenic candidate as well. In the present study, we show that LMP2 may negatively regulate LMS independently of its role in the proteasome. Moreover, several lines of evidence indicate that although calponin h1 does not directly influence tumorigenesis, it clearly affects LMP2-induced cellular morphological changes. Modulation of LMP2 may lead to new therapeutic approaches in human uterine LMS. \u00a9 2012 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved."}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Hayashi,  Takuma"}], "nameIdentifiers": [{"nameIdentifier": "6734", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Horiuchi,  Akiko"}], "nameIdentifiers": [{"nameIdentifier": "6735", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sano,  Kenji"}], "nameIdentifiers": [{"nameIdentifier": "6736", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hiraoka,  Nobuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "6737", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kasai,  Mari"}], "nameIdentifiers": [{"nameIdentifier": "6738", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ichimura,  Tomoyuki"}], "nameIdentifiers": [{"nameIdentifier": "6739", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sudo,  Tamotsu"}], "nameIdentifiers": [{"nameIdentifier": "6740", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nishimura,  Ryuichiro"}], "nameIdentifiers": [{"nameIdentifier": "6741", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishiko,  Osamu"}], "nameIdentifiers": [{"nameIdentifier": "6742", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shiozawa,  Tanri"}], "nameIdentifiers": [{"nameIdentifier": "6743", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kanai,  Yae"}], "nameIdentifiers": [{"nameIdentifier": "6744", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yaegashi,  Nobuo"}], "nameIdentifiers": [{"nameIdentifier": "6745", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aburatani,  Hiroyuki"}], "nameIdentifiers": [{"nameIdentifier": "6746", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Konishi,  Ikuo"}], "nameIdentifiers": [{"nameIdentifier": "6747", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2015-09-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "Potential_role_LMP2_anti-oncogenic_factor.pdf", "filesize": [{"value": "4.4 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 4400000.0, "url": {"label": "Potential_role_LMP2_anti-oncogenic_factor.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/3743/files/Potential_role_LMP2_anti-oncogenic_factor.pdf"}, "version_id": "6a80784d-52b2-4107-a962-44c1f9d2ecd7"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "LMP2", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Calponin h1", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Uterine leiomyosarcoma", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Cell morphology", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: Morphological significance of calponin h1", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: Morphological significance of calponin h1"}]}, "item_type_id": "6", "owner": "1", "path": ["461/462"], "permalink_uri": "http://hdl.handle.net/10091/17585", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_name_i18n": "\u516c\u958b\u65e5", "attribute_value": "2014-06-10"}, "publish_date": "2014-06-10", "publish_status": "0", "recid": "3743", "relation": {}, "relation_version_is_last": true, "title": ["Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: Morphological significance of calponin h1"], "weko_shared_id": 3}